Erasca (ERAS) Earnings Date & Reports

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ERAS is expected to report earnings to fall 15.07% to -11 cents per share on November 11

Q3'26

Est.

$-0.12

Q2'26

Missed

by $0.03

Q1'26

Missed

by $0.49

Q4'25

Beat

by $0.01

Q3'25

Missed

by $0.01

The last earnings report on August 11 showed earnings per share of -14 cents, missing the estimate of -10 cents. With 1.39M shares outstanding, the current market capitalization sits at 6.24B.

View a ticker or compare two or three

ERAS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days